Skip to main content
. 2021 Dec 31;14(1):92. doi: 10.3390/pharmaceutics14010092
AERD Aspirin-Exacerbated Respiratory Syndrome
ACOS Asthma-COPD Overlap Syndrome
AG Andrographolide
ATP Adenosine Triphosphate
BALB/C Bagg and Albino Mice (White Lab Mice)
COPD Chronic Obstructive Pulmonary Disorder
DMPC Dimyristoyl-sn-glycero-3-phosphocholine
DPI Dry Powder Inhaler
FACET Formoterol and Corticosteroids Establishing Therapy
FEV1 Forced Expiratory Volume in the 1st Second
GERD GastroEsophageal Reflux Disease
GOAL Gaining Optimal Asthma controL
HSPC Hydrogenated Soybean Phosphatidylcholine
hUCMSCs Human Umbilical Cord MSCs
ICS Inhaled Corticosteroids
IL Interleukin
ILC2s Group 2 Innate Lymphoid Cells
LABA/LAMA Long-Acting Beta/Muscarinic Agonist
LRA Leukotriene Receptor Antagonist
miR-1470 Micro RNA 1470
MSC Mesenchymal Stem Cell
MSC-Exo Exosomes Derived from Mesenchymal Stem Cells
PLGA Polylactide-co-glycolide
pMDI Pressurized Metered Dose Inhaler
poly(I:C) Polyinosin-polycytidylic acid
sEV MSC-small Extracellular Vesicles
SPIO Superparamagnetic Nanoparticles of Iron Oxides